The Great North Children's Hospital is a tertiary referral centre in Newcastle upon Tyne, England. The hospital is managed by the Newcastle upon Tyne Hospitals NHS Foundation Trust and is a teaching hospital for the University of Newcastle upon Tyne.

There are 246 beds in Great North Children's Hospital.

During the past decade, Great North Children's Hospital conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 1 clinical trials were completed, i.e. on average, 12.5% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Great North Children's Hospital" #1 sponsor was "Bellicum Pharmaceuticals" with 1 trials, followed by "Great Ormond Street Hospital for Children NHS Foundation Trust" with 1 trials sponsored, "Hoffmann-La Roche" with 1 trials sponsored, "Jazz Pharmaceuticals" with 1 trials sponsored and "King's College London" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Great North Children's Hospital" #1 collaborator was "Newcastle-upon-Tyne Hospitals NHS Trust" with 3 trials as a collaborator, "Cambridge University Hospitals NHS Foundation Trust" with 2 trials as a collaborator, "Sheffield Children's NHS Foundation Trust" with 2 trials as a collaborator, "University Hospital Southampton NHS Foundation Trust" with 2 trials as a collaborator and "University Hospitals, Leicester" with 2 trials as a collaborator. Other collaborators include 47 different institutions and companies that were collaborators in the rest 57 trials.

According to Clinical.Site data, the most researched conditions in "Great North Children's Hospital" are "ALK Fusion-positive Solid or CNS Tumors" (1 trials), "Acute Lymphoblastic Leukemia" (1 trials), "Allogeneic Haematopoietic Stem Cell Transplantation" (1 trials), "Anemia, Aplastic" (1 trials) and "Anemia, Sickle Cell" (1 trials). Many other conditions were trialed in "Great North Children's Hospital" in a lesser frequency.

Most popular intervention types in "Great North Children's Hospital" are "Drug" (5 trials), "Biological" (2 trials), "Diagnostic Test" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "177Lu-DTPA-omburtamab" (1 trials), "5Fluorouracil" (1 trials), "Adalimumab" (1 trials), "Alectinib" (1 trials) and "BPX-501 T cells" (1 trials). Other intervention names were less common.

The vast majority of trials in "Great North Children's Hospital" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Great North Children's Hospital". 1 are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Great North Children's Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Great North Children's Hospital, 3 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".